| Title: | Age-dependent effect of APOE and polygenic component on Alzheimer's disease |
| Journal: | Neurobiology of Aging |
| Published: | 30 Apr 2020 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/32464432/ |
| DOI: | https://doi.org/10.1016/j.neurobiolaging.2020.04.024 |
| Citations: | 40 (23 in last 2 years) as of 8 Aug 2024 |
Publication 3138
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Alzheimer's disease (AD) is a devastating neurodegenerative condition with significant genetic heritability. Several genes have been implicated in the onset of AD with the apolipoprotein E (APOE) gene being the strongest single genetic risk loci. Evidence suggests that the effect of APOE alters with age during disease progression. Here, we aim to investigate the impact of APOE and other variants outside the APOE region on AD risk in younger and older participants. Using data from both the Alzheimer's Disease Neuroimaging Initiative and the UK Biobank, we computed the polygenic risk score of each individual informed by the latest genetic study from the International Genomics of Alzheimer's Project. Our analysis showed that the effect of APOE on the disease risk is greater in younger participants and reduces as participants' age increases. Our findings indicate the increased impact of polygenic risk score as participants' age increases. Therefore, AD in older individuals can potentially be triggered by the cumulative effect of genes which are outside the APOE region.9 Authors
- Eftychia Bellou
- Emily Baker
- Ganna Leonenko
- Matthew Bracher-Smith
- Paula Daunt
- Georgina Menzies
- Julie Williams
- Valentina Escott-Price
- the Alzheimer's Disease Neuroimaging Initiative
1 Application
| Application ID | Title |
|---|---|
| 15175 | Further defining the genetic architecture of Alzheimer's disease |
Enabling scientific discoveries that improve human health